DrugDashboards
← Home
Manufacturing facility

Pillar5 Pharma Inc

A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.

Country
Canada
Registered address
365 Madawaska Blvd., Arnprior, Ontario K7S 0C9, Canada (CAN)
Operations here
analysislabelmanufacturepack
FDA identifiers
FEI 3000241849 · DUNS 243904344

FDA inspection history

Outcomes of closed FDA inspections at this site (drug and biologic program areas).

  • VAIDrug Quality Assurance2025-02-07
  • OAIDrug Quality Assurance2023-12-15
  • VAIDrug Quality Assurance2020-02-21
  • NAIDrug Quality Assurance2018-05-17
  • VAIDrug Quality Assurance2015-02-06
  • NAIDrug Quality Assurance2013-05-31
  • NAIDrug Quality Assurance2011-07-22
  • VAIDrug Quality Assurance2008-10-17

Drugs this plant is listed as making

2 distinct drugs across 2 products name this site in their FDA label.

Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.